Restoril

Restoril is a brand name for temazepam, an intermediate-acting benzodiazepine medication primarily used for the short-term treatment of insomnia.

Description: Restoril works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which reduces neuronal excitability and produces a sedative effect, helping individuals fall asleep and stay asleep. It is typically prescribed for a short period, usually 7 to 10 days, to help manage acute insomnia. Like other benzodiazepines, long-term use of Restoril can lead to physical dependence, tolerance, and withdrawal symptoms upon discontinuation. Restoril also has the potential for abuse and is often misused in combination with other substances.

Restoril and Drug Testing: As an intermediate-acting benzodiazepine, Restoril can be detected in various types of drug tests for a moderate period. In urine tests, Restoril and its metabolites can be detected for up to 5-7 days after last use, depending on factors such as dosage, frequency of use, and individual metabolism. In hair tests, Restoril can be detected for up to 90 days after last use. It is crucial for individuals who are prescribed Restoril to inform employers or testing authorities to avoid false-positive results and potential consequences.

Examples:

• Short-term treatment of insomnia
• Management of sleep disturbances associated with anxiety disorders
• Preoperative sedation